Myriad Genetics, Inc. (MYGN)
5.82
+0.06
(+1.04%)
USD |
NASDAQ |
Oct 23, 16:00
5.835
+0.02
(+0.26%)
After-Hours: 20:00
Myriad Genetics Enterprise Value : 651.69M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 651.69M |
| October 22, 2026 | 645.96M |
| October 21, 2026 | 627.79M |
| October 20, 2026 | 624.92M |
| October 19, 2026 | 497.78M |
| October 16, 2026 | 475.79M |
| October 15, 2026 | 511.16M |
| October 14, 2026 | 492.04M |
| October 13, 2026 | 485.35M |
| October 12, 2026 | 496.82M |
| October 09, 2026 | 507.34M |
| October 08, 2026 | 496.82M |
| October 07, 2026 | 504.47M |
| October 06, 2026 | 504.47M |
| October 05, 2026 | 533.15M |
| October 02, 2026 | 529.32M |
| October 01, 2026 | 483.44M |
| September 30, 2026 | 507.34M |
| September 29, 2026 | 499.69M |
| September 28, 2026 | 500.64M |
| September 25, 2026 | 493.95M |
| September 24, 2026 | 491.08M |
| September 23, 2026 | 478.66M |
| September 22, 2026 | 479.61M |
| September 21, 2026 | 478.66M |
| Date | Value |
|---|---|
| September 18, 2026 | 467.18M |
| September 17, 2026 | 491.08M |
| September 16, 2026 | 464.32M |
| September 15, 2026 | 466.23M |
| September 14, 2026 | 457.62M |
| September 11, 2026 | 422.25M |
| September 10, 2026 | 416.52M |
| September 09, 2026 | 400.26M |
| September 08, 2026 | 399.31M |
| September 04, 2026 | 400.26M |
| September 03, 2026 | 404.09M |
| September 02, 2026 | 404.09M |
| September 01, 2026 | 399.31M |
| August 31, 2026 | 403.13M |
| August 28, 2026 | 397.40M |
| August 27, 2026 | 399.31M |
| August 26, 2026 | 393.57M |
| August 25, 2026 | 400.26M |
| August 24, 2026 | 386.88M |
| August 21, 2026 | 401.22M |
| August 20, 2026 | 403.13M |
| August 19, 2026 | 400.26M |
| August 18, 2026 | 369.67M |
| August 17, 2026 | 386.88M |
| August 14, 2026 | 384.97M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Natera, Inc. | 57.16B |
| Labcorp Holdings, Inc. | 33.25B |
| Sera Prognostics, Inc. | 36.62M |
| BioRestorative Therapies, Inc. | -1.494M |
| CareDx, Inc. | 3.209B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -43.20M |
| Revenue (Quarterly) | 190.70M |
| Total Expenses (Quarterly) | 233.90M |
| EPS Diluted (Quarterly) | -0.4557 |
| Gross Profit Margin (Quarterly) | 62.51% |
| Profit Margin (Quarterly) | -22.65% |
| Earnings Yield | -20.59% |
| Normalized Earnings Yield | -19.55 |